Upgrade to SI Premium - Free Trial

Biogen (BIIB) Acquires Muscle Enhancement Program from AliveGen

July 24, 2018 6:42 AM
In addition to earnings, Biogen (NASDAQ: BIIB) announced it has acquired ALG-801 (Phase 1a) and ALG-802 (preclinical) from AliveGen, Inc ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Mergers and Acquisitions

Next Articles